Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Cervical Cancer, February 2026

Free Subscription


Abstracts

Retrieve all available abstracts of the following 348 articles:
HTML format


 

Single Articles


  1. Retraction: miR-126-5p Restoration Promotes Cell Apoptosis in Cervical Cancer by Targeting Bcl2l2.
    Oncol Res. 2026;34:30.
    PubMed    
    Abstract available

  2. PANDIT SK, Sen B, Kumar P, Tripathi A, et al
    Anti-cervical cancer potential of apigenin, daidzein, and isokaempferide of Glycyrrhiza glabra Linn. Methanolic extract via network pharmacological analysis.
    In Silico Pharmacol. 2026;14:44.
    PubMed    
    Abstract available

  3. ANUPAMA CV, Devarapalli D, Ahammad SH, Eid MMA, et al
    Cervical cancer cell prediction and detection with high test accuracy based on a reliable automated system.
    3 Biotech. 2026;16:83.
    PubMed    
    Abstract available

  4. KHORRAMABADI SM, Ebrahimi N, Aghbash PS, Ravanlo ZZ, et al
    Silencing HPV: the rise of RNA therapeutics in cervical cancer.
    Infect Agent Cancer. 2026 Jan 29. doi: 10.1186/s13027-026-00733.
    PubMed    
    Abstract available

  5. UMEMIYA M, Kou K, Inayama Y, Kamei J, et al
    Comparison of nedaplatin and cisplatin in concurrent chemoradiotherapy for cervical cancer: a systematic review and meta-analysis.
    Int J Clin Oncol. 2026 Jan 29. doi: 10.1007/s10147-026-02968.
    PubMed    
    Abstract available

  6. ZENG L, Chen Z, Wang K, Yi C, et al
    Epidemiology and prevention of HPV-driven cervical cancer in urban-rural China: a population-based study of 60,280 women.
    Sci Rep. 2026;16:3937.
    PubMed    
    Abstract available

  7. ELFSTROM KM, Dillner J
    Towards faster, better, and cheaper cervical cancer screening.
    Lancet Public Health. 2026;11:e72-e73.
    PubMed    


  8. SULTANA F, Smith M, Saville M, Bateson D, et al
    Uptake and performance of self-collection offered through primary care to all eligible participants in a national cervical screening programme in Australia: a retrospective cohort study.
    Lancet Public Health. 2026;11:e101-e110.
    PubMed    
    Abstract available

  9. XIAO FY, Ma RC, Wang YX, Zhou JW, et al
    [Value of self-sampling cervical exfoliated cells of HPV E6/E7 mRNA detection in cervical cancer screening: a multicenter clinical study].
    Zhonghua Fu Chan Ke Za Zhi. 2026;61:60-66.
    PubMed    
    Abstract available

  10. YUAN M, Hong Y, Feng Y, Sun J, et al
    Cervical Cancer Incidence and Mortality Trends in China: The role of Screening.
    Cancer Lett. 2026 Jan 27:218286. doi: 10.1016/j.canlet.2026.218286.
    PubMed    
    Abstract available

  11. BALE CA, Pearce JV, Deng X, Bandyopadhyay D, et al
    Prognostic value of FDG-PET SUV changes in cervical cancer following radiation therapy: a retrospective cohort study.
    Arch Gynecol Obstet. 2026;313:66.
    PubMed    
    Abstract available

  12. GU X, Yang Y, Zhang Z, Ouyang Y, et al
    Long Non-Coding RNA RAB11B-AS1 Suppresses Cervical Cancer Progression by Upregulating RPL26 Expression.
    Front Biosci (Landmark Ed). 2026;31:47597.
    PubMed    
    Abstract available

  13. WU Z, Huang C, Li R, Li H, et al
    Correction: PRKCI mediates radiosensitivity via the Hedgehog/GLI1 pathway in cervical cancer.
    Front Oncol. 2026;16:1765010.
    PubMed    
    Abstract available

  14. WANG Z, Zhang H, Zhu Y, Jiang Y, et al
    Comprehensive evaluation of prophylactic HPV vaccines: a systematic review and meta-analysis of efficacy, safety, and immunogenicity in males and females.
    Front Immunol. 2026;16:1747082.
    PubMed    
    Abstract available

  15. NGUYEN AT, Duckworth ED, Li RA, Adam TH, et al
    Cervical Cancer Prevention and Treatment Disparities Among Native Hawaiian and Pacific Islanders: A Systematic Review and Meta-Analysis.
    J Surg Oncol. 2026 Jan 28. doi: 10.1002/jso.70200.
    PubMed    
    Abstract available

  16. GENNARI P, Luft D, Meszaros J, Ignatov A, et al
    Incidence, risk factors, and outcomes of ovarian metastasis in early-stage cervical cancer: a population-based analysis of 983 patients.
    Arch Gynecol Obstet. 2026;313:65.
    PubMed    
    Abstract available

  17. ASEFA T, Endale HT, Mengstie TA, Getnet M, et al
    Determinants of cervical cancer screening among women living with HIV in Lesotho using nationally representative 2023/24 DHS data.
    Sci Rep. 2026 Jan 28. doi: 10.1038/s41598-026-37180.
    PubMed    
    Abstract available

  18. KULJARUSNONT S, Karnchanabanyong W, Ruengkhachorn I, Ularnwong M, et al
    Comparative Performance of Visual Inspection with Acetic Acid and Colposcopy for Detection of Cervical Precancer in Women with High-Risk Human Papillomavirus Infection: A Cross-Sectional Study.
    Cancer Control. 2026;33:10732748261422014.
    PubMed    
    Abstract available


  19. Correction to "Self-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline".
    CA Cancer J Clin. 2026;76:e70066.
    PubMed    


  20. JIA X, Da X, Shi J, Wang Y, et al
    Digital health interventions for cervical cancer screening among hard-to-reach women in health-resource-limited areas: Protocol for a controlled trial with historical controls and two randomised intervention arms.
    Digit Health. 2026;12:20552076261416317.
    PubMed    
    Abstract available

  21. ZHUANG Q, Liu Y
    Efficacy and safety of Cadonilimab in the treatment of recurrent/metastatic and advanced cervical cancer: a systematic review and meta-analysis.
    Front Immunol. 2026;16:1729380.
    PubMed    
    Abstract available

  22. KONDLO S, Giyose N, Businge CB, Mbulawa ZZA, et al
    Human Papillomavirus Genotype Landscape Across Cervical Cytology Grades and Impact of HIV Among Women of Eastern Cape Province, South Africa.
    Viruses. 2025;18:65.
    PubMed    
    Abstract available

  23. CINTONI M, Autorino R, Rinaldi RM, Leonardi E, et al
    Clinical Tolerability and Safety of Ketogenic Diet in Patients with Gynecological Malignancies Undergoing Radiotherapy: Preliminary Results of a Prospective, Randomized, Open-Label Trial (KOMPARC).
    Nutrients. 2026;18:312.
    PubMed    
    Abstract available

  24. DAVID LL, Singh M
    Functionalized Core/Shell Gold-Palladium Bimetallic Nanoparticles in Transferrin-Targeted Dual-Drug Delivery in a Cervical Cancer Cell Model.
    Pharmaceuticals (Basel). 2025;19:74.
    PubMed    
    Abstract available

  25. HUSSAIN SS, Maisam M, Younas S, Wang F, et al
    From Functional Food to Therapeutic Prospect: Mechanistic Study of Gypenoside XVII in HeLa Cells.
    Molecules. 2026;31:214.
    PubMed    
    Abstract available

  26. PATINO-MORALES CC, Jaime-Cruz R, Gonzalez-Perez R, Villavicencio-Guzman L, et al
    The Chick Embryo Chorioallantoic Membrane Assay as a Short-Term Exploratory Model for Cervical Cancer Research.
    Life (Basel). 2026;16:135.
    PubMed    
    Abstract available

  27. TOROMANI G, Saglimbeni GS, Upadhyayula BS, Manu E, et al
    Comprehensive Genomic Characterization of 102 Cervical Adenocarcinoma Tumors.
    Medicina (Kaunas). 2026;62:123.
    PubMed    
    Abstract available

  28. GORGULU G, Sanci M
    Perspectives from Hysterectomy Specimens on the Hidden Malignancy Risk in HSIL Patients with Surgical Margin Continuity.
    Medicina (Kaunas). 2025;62:77.
    PubMed    
    Abstract available

  29. IBIS K, Aydin MH, Kokce K, Suncak L, et al
    The "Undefined and Ignored Normal Tissue" Bulboclitoral Complex in Locally Advanced Cervical Cancer Treated with Definitive Radiochemotherapy: Is It Not the Organ at Risk?
    Medicina (Kaunas). 2025;62:14.
    PubMed    
    Abstract available

  30. SEMENOV DV, Tatarnikova IS, Chesnokova AS, Talyshev VA, et al
    Single-Cell Transcriptomic Landscape of Cervical Cancer Cell Lines Before and After Chemoradiotherapy.
    Cells. 2026;15:115.
    PubMed    
    Abstract available

  31. LEGAKI E, Lappa T, Prasoula KL, Kardasi Z, et al
    HPV-Driven Cervical Carcinogenesis: Genetic and Epigenetic Mechanisms and Diagnostic Approaches.
    Int J Mol Sci. 2026;27:803.
    PubMed    
    Abstract available

  32. LAGUNAS-CRUZ MDC, Valle-Mendiola A, Soto-Cruz I
    The Vaginal Microbiome and Host Health: Implications for Cervical Cancer Progression.
    Int J Mol Sci. 2026;27:640.
    PubMed    
    Abstract available

  33. MARTINEZ-RAMIREZ I, Munoz-Bello JO, Contreras-Paredes A, Parra-Hernandez E, et al
    Cholesterol Metabolism: An Ally in the Development and Progression of Cervical Cancer.
    Int J Mol Sci. 2026;27:591.
    PubMed    
    Abstract available

  34. KIM J, Jang J, Tewari KS, Kim KS, et al
    Nationwide Survival Impact of Bevacizumab Under National Reimbursement for Advanced Cervical Cancer in South Korea.
    Cancers (Basel). 2026;18:346.
    PubMed    
    Abstract available

  35. DU M, Zheng Z, Lu P, Wang W, et al
    Oncological Outcomes and Genomic Features of Gastric-Type Endocervical Adenocarcinoma, the Most Aggressive and Common HPV-Independent Cervical Cancer.
    Cancers (Basel). 2026;18:320.
    PubMed    
    Abstract available

  36. KARNIK M, Tulimilli SV, Anantharaju PG, Bettadapura ADS, et al
    An Overview of the Mechanisms of HPV-Induced Cervical Cancer: The Role of Kinase Targets in Pathogenesis and Drug Resistance.
    Cancers (Basel). 2026;18:318.
    PubMed    
    Abstract available

  37. MAREMA TP, Laka K, Mbita Z
    Medicinal Plants for Overcoming Drug Resistance in Cervical Cancer.
    Biology (Basel). 2026;15:191.
    PubMed    
    Abstract available

  38. EMADI SH, Ahmad S, Rahmanian M, Baharlou R, et al
    Design and computational evaluation of a prophylactic and therapeutic multi-epitope vaccine candidate against cervical cancer.
    Virol J. 2026 Jan 27. doi: 10.1186/s12985-026-03072.
    PubMed    
    Abstract available

  39. WAN Y, He Y, Chen X, Wang S, et al
    Effective delivery of genome editor to cervical cancer targeting Mcl1 for cancer therapy.
    Cancer Gene Ther. 2026 Jan 27. doi: 10.1038/s41417-025-00958.
    PubMed    
    Abstract available

  40. VENGHATERI JB, Nathani P, Kaur J, Gadgil A, et al
    India's Path to Cervical Cancer Control: From Obstacles to Opportunities in HPV Vaccine Uptake.
    Public Health Res Pract. 2026 Jan 20:PU25036. doi: 10.1071/PU25036.
    PubMed    
    Abstract available

  41. WILKINSON AN, Wright K, Savage C, Pearl D, et al
    Towards Cervical Cancer Elimination: Insights from an In-Depth Regional Review of Patients with Cervical Cancer.
    Curr Oncol. 2026;33:52.
    PubMed    
    Abstract available

  42. NAGDEV P, Chittilla M
    Advances in Screening, Immunotherapy, Targeted Agents, and Precision Surgery in Cervical Cancer: A Comprehensive Clinical Review (2018-2025).
    Curr Oncol. 2026;33:48.
    PubMed    
    Abstract available

  43. XIAO H, Guo F, Wang Z, Pei K, et al
    Is Moderately Hypofractionated Radiotherapy a Safe and Effective Strategy for Cervical Cancer?-A Review of Current Evidence.
    Curr Oncol. 2026;33:24.
    PubMed    
    Abstract available

  44. ZAMUDIO CANAS R, Vallejo Ruiz V, Jaramillo Flores ME, Delgado Macuil RJ, et al
    Detection of Premalignant Cervical Lesions via Maackia amurensis Lectin-Based Biosensors.
    Biosensors (Basel). 2025;16:24.
    PubMed    
    Abstract available

  45. LEONI F, Giorgi Rossi P, Morana C, Marchione R, et al
    Conservative Management of CIN2 Within Primary HPV Cervical Cancer Screening Programme: A Cohort Study.
    J Low Genit Tract Dis. 2026 Jan 26. doi: 10.1097/LGT.0000000000000930.
    PubMed    
    Abstract available

  46. SELVAJOTHI J, Hewitt M, de Haan A, Ting S, et al
    Managing women with cervical cancer symptoms: Cervical One-Stop Assessment Clinic.
    Ir Med J. 2026;119:9.
    PubMed    
    Abstract available

  47. OMI M, Saito M, Nishino S, Fusegi A, et al
    Case report on critical well-leg compartment syndrome: early diagnosis and treatment after cervical cancer surgery.
    Int Cancer Conf J. 2025;15:25-29.
    PubMed    
    Abstract available

  48. BONLOKKE S, Blaakaer J, Steiniche T, Iachina M, et al
    Increased Risk of Second Squamous Cell Carcinomas Following Cervical Cancer: A Nationwide Danish Case-Control Study.
    Cancer Med. 2026;15:e71559.
    PubMed    
    Abstract available

  49. HUANG C, Pang G, Lang X, Zhang J, et al
    Single-Cell RNA Sequencing Analysis Reveals Correlation Between Immune Cell Composition and Gene Expression in Cervical Cancer.
    J Cell Mol Med. 2026;30:e70998.
    PubMed    
    Abstract available

  50. CHEN L, Liu L, Lin F, Fu Y, et al
    Development and Validation of Prediction Models for the Prognosis of Clear Cell Adenocarcinoma of the Cervix: A Population-Based Cohort Study.
    Cancer Med. 2026;15:e71585.
    PubMed    
    Abstract available

  51. XIAO Y, Zhao Y, Wang Z, Peng C, et al
    Ferroptosis Targeting by beta-Sitosterol in Cervical Cancer Radiotherapy.
    Curr Med Chem. 2026 Jan 19. doi: 10.2174/0109298673409273251103055503.
    PubMed    
    Abstract available

  52. LI W, Yan Q, Zhou D, Yin X, et al
    Disparities in early-stage cervical cancer detection: the critical role of educational attainment in 75,268 women in Hubei Province.
    BMC Public Health. 2026 Jan 26. doi: 10.1186/s12889-025-26056.
    PubMed    


  53. SIFERIH M, Gedif G, Lamesgen A, Alamneh AA, et al
    Point-of-care HPV testing for cervical cancer screening in Sub-Saharan Africa: platform diversity, diagnostic performance, implementation feasibility, and determinants-a scoping review with contextual considerations for Ethiopia.
    BMC Public Health. 2026 Jan 26. doi: 10.1186/s12889-026-26382.
    PubMed    


  54. SAMBATH J, George IA, Manda SS, Ariyannur P, et al
    Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancer.
    Mol Oncol. 2026 Jan 26. doi: 10.1002/1878-0261.70108.
    PubMed    
    Abstract available

  55. DE LA CRUZ-HERNANDEZ E, Morales-Sandoval GC, Lizano M, Aviles-Salas A, et al
    Prognostic value of glioma-associated oncogene homolog 1 and SET domain-containing protein 2 immunohistochemical scores in locally advanced cervical cancer.
    Oncol Lett. 2026;31:105.
    PubMed    
    Abstract available

  56. LIU Y, Wu R, Zhang L
    A cross-sectional study on the quality of cervical cancer health information across multiple short video platforms: Analysis of content, quality, and dissemination characteristics.
    Digit Health. 2026;12:20552076261415927.
    PubMed    
    Abstract available

  57. GOVENDER S, Phillips TK, Walter FM, Day S, et al
    Cervical cancer awareness among women recently diagnosed with cervical cancer in South Africa and Zimbabwe.
    Ecancermedicalscience. 2025;19:2018.
    PubMed    
    Abstract available

  58. NARTEY Y, Osae-Larbi J, Daniels J
    Cervical cancer screening in women with disabilities in Ghana: bridging the gap in access and equity.
    AJOG Glob Rep. 2025;6:100597.
    PubMed    
    Abstract available

  59. JI R, Geng R, Zhang Z, Gao F, et al
    Exploring the Dynamic Changes of Intercellular Connections in Cervical Cancer: Insights From Transcriptomic Data Combined With Single-Cell Sequencing.
    Hum Mutat. 2026;2026:8140041.
    PubMed    
    Abstract available

  60. GO AE, Feliciano EJG, Martinez J, Ho FDV, et al
    Global determinants of cervical cancer outcomes: a health systems analysis.
    BMJ Oncol. 2026;5:e000975.
    PubMed    
    Abstract available

  61. SUN Y, Zhang J, Guo L, Zhang J, et al
    Discovering the abnormalities and functional importance of ferroptosis-related molecules in cervical cancer.
    Int J Med Sci. 2026;23:443-460.
    PubMed    
    Abstract available

  62. YU H, Chen J, Lin J, Chen L, et al
    Cadonilimab rechallenge in patients with recurrent or metastatic cervical cancer following prior PD-1/PD-L1 inhibitor failure: a retrospective multicenter study.
    Front Immunol. 2026;16:1701319.
    PubMed    
    Abstract available

  63. AMBOREE TL, Dorali P, Damgacioglu H, Montealegre JR, et al
    The cervical cancer divide: State variation in incidence, mortality, and progress toward elimination in the US.
    JNCI Cancer Spectr. 2026 Jan 25:pkag005. doi: 10.1093.
    PubMed    
    Abstract available

  64. DANIELS-DONKOR SS, Marryat L
    Health system barriers and facilitators influencing the uptake of cervical cancer screening among women in sub-Saharan Africa: systematic review and meta-synthesis.
    BMC Health Serv Res. 2026 Jan 24. doi: 10.1186/s12913-026-14003.
    PubMed    


  65. POLEBOYINA PK, Pawar SC
    Elucidation of MMP-9 expression and association of MMP-9 rs3918242-1562 C/T promoter polymorphism in the progression of cervical cancer.
    Cancer Genet. 2026;302-303:79-92.
    PubMed    
    Abstract available

  66. ABAR B, Wood N, Merriman J, Adler D, et al
    Test results and follow-up care stemming from an ED-based cervical cancer intervention.
    Am J Emerg Med. 2026;102:78-80.
    PubMed    
    Abstract available

  67. LI J, Zhong X, Mou Y, Tao X, et al
    Identification of dephosphorylation related genes prognostic signature in cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Medicine (Baltimore). 2026;105:e47292.
    PubMed    
    Abstract available

  68. ZHENG H, Gao M, Xu H, Cai J, et al
    Initial different human papillomavirus infection statuses and subsequent infection risk: a decade-long longitudinal study.
    J Health Popul Nutr. 2025;45:32.
    PubMed    
    Abstract available

  69. MABIKA-OBANDA AKF, Ambounda Ledaga N, Ngou Milama K, Zang Obame V, et al
    Vaccine-preventable HPV burden and cervical abnormalities in women during 2022-2024 Octobre Rose campaigns in Libreville.
    Nat Commun. 2025;17:1032.
    PubMed    
    Abstract available

  70. HAHN E, Zakaras JM, Balasubramanian A, Russo A, et al
    Identifying gaps in women's preventive health services for women living with HIV in Vermont.
    Reprod Health. 2025;23:15.
    PubMed    
    Abstract available

  71. PITAKKARNKUL S, Tangjitgamol S, Sangariyavanich E, Buasom R, et al
    The situation of gynecological cancers in Thailand: incidence, histopathology, and survival outcomes from national cancer registry data.
    J Gynecol Oncol. 2026;37:e56.
    PubMed    
    Abstract available

  72. BRENNAN LP, Hamacher F, Claure LA, Claure Dips AL, et al
    Development of an HPV 16 rapid test founded in user-centered design with primary care clinicians.
    Anal Methods. 2026;18:786-799.
    PubMed    
    Abstract available

  73. TONG Y, Xu L, Sun Y, Lan Y, et al
    Construction of a nomogram model for predicting residual or recurrent cervical intraepithelial neoplasia after the loop electrosurgical excision procedure.
    Am J Clin Pathol. 2026;165:aqaf125.
    PubMed    
    Abstract available

  74. SHARMA S, Verma M, Rautela I, Khan F, et al
    Tumor Microenvironment: From Cervical Carcinogenesis to Therapeutic Advancements.
    Curr Pharm Biotechnol. 2025;26:2065-2081.
    PubMed    
    Abstract available

  75. CHEN J, Wu M, Zhang R, Cao Y, et al
    Luteolin, a Bioactive Compound from Celastrus orbiculatus Stem, Inhibits Cervical Cancer via CA2 Suppression: A Translational Study Bridging Basic Research and Clinical Application.
    J Ethnopharmacol. 2026 Feb 4:121326. doi: 10.1016/j.jep.2026.121326.
    PubMed    
    Abstract available

  76. SMITH MA, Killen J, Jamieson L, O'Farrell X, et al
    Accelerating cervical cancer elimination in Aboriginal and Torres Strait Islander women: a modelling study.
    Lancet Public Health. 2026 Feb 3:S2468-2667(26)00005.
    PubMed    
    Abstract available

  77. ZHANG L, Zhang S, Liu S, Jian W, et al
    Human Papillomavirus Vaccination Policies and Discourse on Social Media.
    JAMA Health Forum. 2026;7:e256425.
    PubMed    
    Abstract available

  78. FOKOM DOMGUE J, Chandra M, Oladoyin O, Desai M, et al
    Women's Preferences for Home-Based Self-Sampling or Clinic-Based Testing for Cervical Cancer Screening.
    JAMA Netw Open. 2026;9:e2558841.
    PubMed    
    Abstract available

  79. LOOS G, Duclos M, Ennequin G
    Physical activity and exercise in cervical cancer: a state-of-the-art review.
    Cancer Causes Control. 2026;37:41.
    PubMed    
    Abstract available

  80. AGYEMAN AA, Bader G, Opoku NKO
    The impact of human papillomavirus vaccination implementation in reducing cervical cancer in a heterosexual population.
    Cancer Causes Control. 2026;37:42.
    PubMed    
    Abstract available

  81. PANG S, Jian X, Wei W, Chen Y, et al
    Phosphoproteins Identification on Stretchable Photonic Crystal for Cervical Cancer Assessment.
    Anal Chem. 2026 Feb 6. doi: 10.1021/acs.analchem.5c05791.
    PubMed    
    Abstract available

  82. JOSTEN K, Rose Dhar R, Reshmi B, Natti Krishna V, et al
    Barriers to HPV vaccination among adolescent girls in India: A scoping review.
    Indian J Med Res. 2026;162:743-753.
    PubMed    
    Abstract available

  83. CHEPKORIR J, Kivuti-Bitok L, Perrin N, Gross D, et al
    Cervical cancer information access and dissemination strategies among rural Kenyan women: A mixed methods study.
    J Public Health Afr. 2026;17:1457.
    PubMed    
    Abstract available

  84. OZGURLUK I, Erdem HB, Alay MT, Oktar O, et al
    Unveiling mitochondrial DNA copy number alterations: Insights into progression from cervical intraepithelial neoplasia to cervical cancer.
    Oncol Lett. 2026;31:117.
    PubMed    
    Abstract available

  85. LOU H, Langan D, Syracuse N, Murphy EA, et al
    A Three-subtype Molecular model of Cervical Cancer: Multiple PI3K Pathway inhibitors suppress growth and cooperate with HPV-directed immunotherapy.
    medRxiv [Preprint]. 2026 Jan 23:2026.01.21.26344562.
    PubMed    
    Abstract available

  86. RODRIGUEZ NM, Case X, Balian L, Ziolkowski R, et al
    Cervical Cancer Screening Rates and Associated Sociodemographic and Behavioral Factors among People Experiencing Homelessness in Indiana.
    Res Sq [Preprint]. 2026 Jan 30:rs.3.rs-8524257. doi: 10.21203/rs.3.rs-8524257.
    PubMed    
    Abstract available

  87. WANG Q, Su M, Zheng Y
    The Application of Tumor-Free Technique in Robotic Single-Site Radical Hysterectomy for Early Stage Cervical Cancer.
    Ann Surg Oncol. 2026 Feb 5. doi: 10.1245/s10434-025-19026.
    PubMed    
    Abstract available

  88. YANG J, Shi Z, Song T, Shao Y, et al
    LncRNA TMPO-AS1 aggravates the cisplatin resistance in cervical cancer via miR-140-5p/DNMT1 axis-mediated DNA methylation of KLK10.
    Med Oncol. 2026;43:136.
    PubMed    
    Abstract available

  89. PENG L, Yu S, Dong Y, Gu H, et al
    A potential association between the characteristics of the multi-organ microbiota and lymph node metastasis in cervical cancer.
    Front Cell Infect Microbiol. 2026;15:1639811.
    PubMed    
    Abstract available

  90. ZHANG J, Shen J, Yuan L
    Effect of HOXB7 in promoting proliferation, invasion and migration of cervical cancer cells.
    Cytotechnology. 2026;78:38.
    PubMed    
    Abstract available

  91. ZHANG Y, Yuan J, Chen L
    Transforming cervical cancer pathological diagnosis through artificial intelligence: progress, performance, and barriers to clinical implementation.
    Front Oncol. 2026;15:1716018.
    PubMed    
    Abstract available

  92. NEWHOUSE R, McWilliams L, Baker-Rand H, Cullimore V, et al
    Investigating the Acceptability of Cervical Screening and Self-Sampling in Postnatal Women at the 6-Week Postnatal Check-Up: A Qualitative Study.
    Health Expect. 2026;29:e70582.
    PubMed    
    Abstract available

  93. ALLIN T, Taunton C, Ketchell F, Hempenstall A, et al
    High Cervical Cancer Screening Rates and Low Human Papillomavirus Detection in the Remote Torres Strait, Far North Queensland.
    Aust N Z J Obstet Gynaecol. 2026;66:e70060.
    PubMed    
    Abstract available

  94. TATARNIKOVA I, Talyshev V, Sen'kova A, Markov O, et al
    Two paired HPV-59 cervical cancer cell lines with distinct chemoradioresistant phenotypes.
    Sci Rep. 2026 Feb 4. doi: 10.1038/s41598-026-36260.
    PubMed    


  95. LEINO A, Numminen E, Kares S, Merio M, et al
    Clinical relevance of partial HPV genotyping in cervical cancer screening.
    Sci Rep. 2026 Feb 4. doi: 10.1038/s41598-026-36594.
    PubMed    
    Abstract available

  96. TIAN X, Cao C, Wang L, Zhang J, et al
    Testing menstrual blood for human papillomavirus during cervical cancer screening in China: cross sectional population based study.
    BMJ. 2026;392:e084831.
    PubMed    
    Abstract available

  97. DOU J, Liu Z
    Mapping interventions to increase uptake of breast and cervical cancer screening along the Intervention Ladder: a systematic review.
    Health Psychol Rev. 2026 Feb 4:1-30. doi: 10.1080/17437199.2026.2623887.
    PubMed    
    Abstract available

  98. SCHWAB R, Emrich K, Heimes AS, Schwarzer K, et al
    Combined Cervical Cancer Screening and the Incidence of Adenocarcinoma: An Analysis of Data From the German Cancer Registries.
    Dtsch Arztebl Int. 2026;.
    PubMed    
    Abstract available

  99. MILERAD H, Bonander C, Nordqvist Kleppe S, Dillner J, et al
    [Geomapping of 10-year coverage rate of cervical cancer screening in Sweden - a basis for targeting population-level interventions to improve screening].
    Lakartidningen. 2026;123:25052.
    PubMed    
    Abstract available

  100. RAJAIE S, Emamgholipour S, Azari S, Karimi Z, et al
    Acceptance and the willingness to pay for human papilloma virus (HPV) vaccine: A systematic review.
    Hum Vaccin Immunother. 2026;22:2609345.
    PubMed    
    Abstract available

  101. SHEN Y, Kang M
    Retrospective analysis of preoperative serum tumor marker levels and their correlation with pathological characteristics and prognosis in cervical cancer patients.
    Front Genet. 2026;17:1724789.
    PubMed    
    Abstract available

  102. BAHARDOUST M, Ghalavand N, Shamohammadi M, Asl MS, et al
    Pretreatment CRP-Albumin-Lymphocyte (CALLY) Index as a Prognostic Biomarker of Survival and Recurrence-Free Survival in Patients With Early-Stage Cervical Cancer After Radical Hysterectomy: A Multicenter Retrospective Cohort Study.
    Obstet Gynecol Int. 2026;2026:6137796.
    PubMed    
    Abstract available

  103. WISE J
    Cervical cancer: Fewer screening tests needed, study suggests.
    BMJ. 2026;392:s224.
    PubMed    


  104. LU X, Yao L, Xu X, Rexiti MG, et al
    m5c-modified LINC01094 participates in epithelial-mesenchymal transition and metastasis of cervical cancer cells via the ZNF582-SIRT1/p53 axis.
    Mamm Genome. 2026;37:32.
    PubMed    
    Abstract available

  105. NING B, Li Z, Yu D, Li C, et al
    Deep learning and dual-radiomics model incorporating brachytherapy applicator type to predict radiation-induced acute rectal injury in cervical cancer patients.
    Phys Imaging Radiat Oncol. 2026;37:100908.
    PubMed    
    Abstract available

  106. POLANE MG, Dlamini SB
    A qualitative study exploring the primary health care nurses' lived experiences of cervical cancer screening.
    Afr J Prim Health Care Fam Med. 2026;18:e1-e9.
    PubMed    
    Abstract available

  107. KAYA M, Kara Y, Sanli-Mohamed G
    Anticancer Properties of Newly Synthesized Pyrrole Derivatives as Potential Tyrosine Kinase Inhibitors.
    J Biochem Mol Toxicol. 2026;40:e70665.
    PubMed    
    Abstract available

  108. JAHANSHAHI S, Soleimani-Jelodar R, Jalilvand S, Shoja Z, et al
    Investigation of the expression level of human endogenous retrovirus E env transcript in cervical cancer.
    Retrovirology. 2026 Feb 2. doi: 10.1186/s12977-025-00672.
    PubMed    
    Abstract available

  109. AYSI?N N, Kurt Can E, Koltas S, Yilmaz M, et al
    A qualitative study on the experiences of stigmatisation and spiritual coping among women diagnosed with cervical cancer in Turkey.
    BMC Womens Health. 2026 Feb 2. doi: 10.1186/s12905-026-04318.
    PubMed    


  110. HARIPRASAD R, Bhatnagar T
    A Systematic Framework for Evaluating Cervical Cancer Screening Programs: Innovative Approaches and Best Practices.
    Indian J Public Health. 2026;70.
    PubMed    
    Abstract available

  111. MABROUK NOUH F, Abualruz H, Al-Zoubi M, Al-Mugheed K, et al
    Nursing students' knowledge and attitudes toward human papillomavirus vaccination and infection.
    Hum Vaccin Immunother. 2026;22:2609329.
    PubMed    
    Abstract available

  112. XIA W, Wang J, Yang X, Sha Y, et al
    DNA methylation triage of human papillomavirus-positive atypical squamous cells of undetermined significance in cervical cancer screening.
    J Obstet Gynaecol. 2026;46:2623828.
    PubMed    
    Abstract available

  113. PEDERSEN K, Di Silvestre J, Sy S, Portnoy A, et al
    Optimizing Cervical Cancer Screening by Age at Vaccination for Human Papillomavirus: Health and Resource Implications.
    Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-25-03192.
    PubMed    
    Abstract available


  114. Summary for Patients: Optimizing Cervical Cancer Screening by Age at Vaccination for Human Papillomavirus.
    Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-25-03192.
    PubMed    


  115. WENTZENSEN N, Egemen D
    Adapting Cervical Cancer Screening in Vaccinated Populations: Individualized Versus Population-Based Approaches.
    Ann Intern Med. 2026 Feb 3. doi: 10.7326/ANNALS-25-05559.
    PubMed    


  116. HULLON D, Kara Damor D, Singh T, ALKhatib M, et al
    The Overlay of Cervical Cancer with Cardiac Metastasis.
    Cardiology. 2026 Feb 2:1-22. doi: 10.1159/000550823.
    PubMed    
    Abstract available

  117. TJALMA WA
    Rare Today, Common Tomorrow: Strengthening Cervical Cancer Prevention in Low-Incidence Countries is Urgently Needed.
    Int J Prev Med. 2025;16:85.
    PubMed    


  118. ZRAIDI M, Kamel N, El Belloute G, Abidi K, et al
    [Obstetrical characteristics related to cervical cancer in the Northern Territory of the Rabat-Sale-Kenitra Region, Morocco].
    Pan Afr Med J. 2025;52:102.
    PubMed    


  119. ZHANG F, Hu J, Bian J, Lan Y, et al
    Mullerian adenosarcoma mimicking cervical carcinoma in a 79-year-old woman: diagnostic challenges and laparoscopic treatment: a case report.
    Pan Afr Med J. 2025;52:110.
    PubMed    
    Abstract available

  120. WANG R, Liu S, Wang R, Guo Q, et al
    Different Expressions and Methylation Patterns of cGAS and STING in Cervical Cancer.
    Obstet Gynecol Int. 2026;2026:2210380.
    PubMed    
    Abstract available

  121. SHEN X, Guo W, Yao C, Wu H, et al
    Epidemiological analysis of human papillomavirus and its subtype infections in 36,248 women in Wuhan, China.
    Front Public Health. 2026;14:1745604.
    PubMed    
    Abstract available

  122. WANG X, Wang Q, Ding G, Wang J, et al
    Artificial intelligence for colposcopic and cytological image analysis in early cervical cancer detection.
    iScience. 2026;29:114627.
    PubMed    
    Abstract available

  123. ROTHSCHILD H, Keverline K, McKinney S, Farrell M, et al
    From #cervicalcancerscreening to #LEEP - Quality and accuracy of cervical cancer content on TikTok.
    Gynecol Oncol Rep. 2025;63:102018.
    PubMed    
    Abstract available

  124. ADANKWAH E, Mensah ABB, Konney T, Nones M, et al
    A pilot study on the acceptability and feasibility of HPV self-sampling for cervical cancer screening among women attending urban hospitals in Kumasi, Ghana.
    J Cancer Policy. 2026 Jan 30:100710. doi: 10.1016/j.jcpo.2026.100710.
    PubMed    
    Abstract available

  125. GUIDOBALDI L, Cafiero C, Stillitano G, Ricciardi E, et al
    Cervical Cancer Complexity: Exploring the Coexistence of CIN3 and Glandular Lesions.
    Infect Disord Drug Targets. 2026.
    PubMed    
    Abstract available

  126. SHAHRY P, Mohammadi Khoshoei Z, Cheraghi M, Talaiezadeh A, et al
    Population-based epidemiological study of cervical cancer in Khuzestan province, Iran (2014-2019).
    BMC Public Health. 2026 Jan 31. doi: 10.1186/s12889-026-26428.
    PubMed    


  127. SABATIER R, Hennequin C, Martin-Babau J, Follana P, et al
    [French recommendations for clinical practice, Nice-Saint-Paul de Vence 2024-2025: Management of advanced cervical cancer].
    Bull Cancer. 2026 Jan 30:S0007-4551(26)00022.
    PubMed    
    Abstract available

  128. PARIDA P, Mehta A, Raj EA, Guruvare S, et al
    Diagnostic and prognostic significance of circulating HPV cfDNA in cervical cancer: A systematic review and meta-analysis.
    Crit Rev Oncol Hematol. 2026;220:105161.
    PubMed    
    Abstract available

  129. JIANG N, Xin Z, Zhang Y, Liu Y, et al
    Clinical translation of a DWI-radiomics nomogram integrating serum biomarkers for pretreatment staging of cervical cancer.
    BMC Med Imaging. 2026 Jan 30. doi: 10.1186/s12880-026-02175.
    PubMed    


  130. KAIDO Y, Kagabu M, Chiba Y, Sato S, et al
    Safety and oncologic outcomes of total laparoscopic versus abdominal hysterectomy following diagnostic conization for adenocarcinoma in situ and stage IA1 cervical cancer: a multicenter retrospective study.
    Int J Clin Oncol. 2026 Jan 30. doi: 10.1007/s10147-026-02971.
    PubMed    
    Abstract available

  131. CHARGARI C, Martinez A, Michels J, Lecuru F, et al
    [French recommendations for clinical practice, Nice-Saint-Paul-de-Vence 2024-2025: Management of localized cervical cancer].
    Bull Cancer. 2026 Jan 29:S0007-4551(26)00025.
    PubMed    
    Abstract available

  132. SAGER G, Livik M, Hellevik T, Orbo A, et al
    Extracellular cGMP Levels Predict the Response of C4-1 Cervical Cancer Cells to Ionizing Radiation.
    Anticancer Res. 2026;46:611-618.
    PubMed    
    Abstract available

  133. YANG ST, Chang CW, Wang PH
    Clinical impact of glandular involvement in high-grade squamous intraepithelial lesions of the cervix.
    Taiwan J Obstet Gynecol. 2026;65:64-69.
    PubMed    
    Abstract available

  134. IMATAKE H, Taki M, Yamanoi K, Murakami R, et al
    Healthcare provider bias in cancer treatment decisions for elderly patients.
    Taiwan J Obstet Gynecol. 2026;65:29-33.
    PubMed    
    Abstract available

  135. NIRMALKAR AP, Mamulwar M, Godbole S, Shahabuddin SM, et al
    Cost-effectiveness of cervical cancer screening among women living with HIV in India: study protocol.
    BMJ Open. 2026;16:e108752.
    PubMed    
    Abstract available

  136. PENG Z, Liu C, Tang D, Li S, et al
    Slice-prompted HR-CTV interactive segmentation for cervical cancer brachytherapy: A multi-center study.
    Med Phys. 2026;53:e70305.
    PubMed    
    Abstract available

  137. ZHOU Z, Li J, Zhao X, Xu H, et al
    Gramine Suppresses Cervical Cancer by Targeting CDK2: Integrated Omics-Pharmacology and In Vitro Evidence.
    Curr Issues Mol Biol. 2026;48:64.
    PubMed    
    Abstract available

  138. LEI X, Yang W, Xu S, Wu H, et al
    Regulation of Energy Metabolism and Lipid Metabolites by IMP3 in Cervical Cancer.
    Curr Issues Mol Biol. 2025;47:1014.
    PubMed    
    Abstract available

  139. VIDALINA D, Ghali L, Kassouf N, Li S, et al
    The Therapeutic Effect of EZH2 Inhibitors in Targeting Human Papillomavirus Associated Cervical Cancer.
    Curr Issues Mol Biol. 2025;47:990.
    PubMed    
    Abstract available

  140. GHOLAMI S, Aghbash PS, Ravanlo ZZ, Rahimi SB, et al
    Therapeutic targeting of the HPV E7 oncoprotein: Current advances and emerging strategies.
    Int Immunopharmacol. 2026;172:116193.
    PubMed    
    Abstract available

  141. COBLENTZ EG, Packee CR, Ky SL, Brubaker AG, et al
    Prioritization of HPV vaccine preventable diseases among emerging adults - Implications for health education and communication.
    Vaccine. 2026;74:128223.
    PubMed    
    Abstract available

  142. XIE X, Liu C, Liu X, Hou L, et al
    Indirubin treatment was associated with modulation of the PI3K/AKT and MAPK pathways and induction of apoptosis and autophagy.
    Sci Rep. 2026;16:5155.
    PubMed    
    Abstract available

  143. YI H, Huang J, Zhang N, Sundquist J, et al
    The association of post-conization pregnancy with subsequent cervical lesions: evidence from a nationwide cohort in Sweden.
    BMC Med. 2025;24:61.
    PubMed    
    Abstract available

  144. WANG Z, Hu T, Liu W, Zhou H, et al
    Development and clinical validation of an ERA-CRISPR/Cas12a assay for the rapid detection of 14 high-risk HPV types.
    Microbiol Spectr. 2026;14:e0303625.
    PubMed    
    Abstract available

  145. SHI L, Gao X, Huang L, Gao Z, et al
    Efficacy, safety and immunogenicity of a recombinant human papillomavirus bivalent (types 16, 18) vaccine in healthy 18-30-year-old Chinese women: a phase III, double-blind, randomized, controlled trial.
    BMC Infect Dis. 2025;26:248.
    PubMed    
    Abstract available

  146. CONTRERAS GARDUNO S, Saraiba-Rabanales V, Chavarri-Guerra Y, Soto-Perez-de-Celis E, et al
    Trends in Cervical Cytology Test Reports and Cervical Dysplasia Severity according to Social Deprivation in Mexico (2013-2019): An Analysis of a National Database.
    Cancer Epidemiol Biomarkers Prev. 2026;35:341-347.
    PubMed    
    Abstract available

  147. AHADI L, Zarei F, Kazemnejad A
    From screen to screening: a randomized controlled trial on mHealth vs. traditional training on knowledge, attitudes, practice, self-efficacy, and adherence intention to pap smear.
    BMC Womens Health. 2025;26:61.
    PubMed    
    Abstract available

  148. DALAL S, Sundstrom K, Silva R, Taghavi K, et al
    Age-specific distribution of cervical precancer and cancer among women living with HIV across seven countries: a systematic review and an individual patient data meta-analysis.
    Lancet HIV. 2026;13:e126-e137.
    PubMed    
    Abstract available

  149. TRAN CT, Wang M, Plymoth M, Chen J, et al
    Accuracy of Self-Reported Cervical Screening Status Among Pregnant Women.
    Aust N Z J Obstet Gynaecol. 2025 Nov 26. doi: 10.1111/ajo.70057.
    PubMed    
    Abstract available

  150. RUAN J, Gao C, Wang R, Hu B, et al
    A novel dual-effect bimodal chip cancer research platform: Chips system interconnected vascularized tumor organoids culture with real-time exploration and detection from bench to bedside.
    Cancer Lett. 2026;640:218110.
    PubMed    
    Abstract available

  151. ZHANG Z, Kong D, Ding Y, Lu M, et al
    Laser ablation combined with photodynamic therapy for complex vaginal HSIL after repeat cervical conizations: a case report.
    Photodiagnosis Photodyn Ther. 2026;57:105267.
    PubMed    
    Abstract available

  152. WANG Z, Luo H
    Diagnostic Value of Ultrasound in Primary Cervical Ewing's Sarcoma: Two Case Reports and Literature Review.
    J Clin Ultrasound. 2026;54:490-498.
    PubMed    
    Abstract available

  153. YANG L, Zou Y, Tian R
    Cervical Paraganglioma Negative on Both 68Ga-DOTATATE and 18F-FDG PET/CT Studies.
    Clin Nucl Med. 2025 Apr 24. doi: 10.1097/RLU.0000000000005895.
    PubMed    
    Abstract available

  154. FENG H, Zhao J, Zhang J, Jia P, et al
    The role of E7 oncoprotein self-sampling and self-testing in cervical cancer screening.
    BMC Womens Health. 2026 Feb 16. doi: 10.1186/s12905-026-04336.
    PubMed    


  155. DISILVESTRO JB, Scott A, Novetsky AP, Perkins RB, et al
    A Lens into the Quality Standards of Modern-Day Colposcopy.
    Obstet Gynecol Clin North Am. 2026;53:121-138.
    PubMed    
    Abstract available

  156. ANDERSSON H, Dillner J
    Population-based cervical screening with Human Papillomavirus self-sampling at home and incidence of cervical cancer in Sweden.
    Prev Med. 2026 Feb 13:108540. doi: 10.1016/j.ypmed.2026.108540.
    PubMed    
    Abstract available

  157. ANDERSON EM, Saah AJ, Tota JE
    HPV Type Replacement After HPV Vaccination.
    Curr Top Microbiol Immunol. 2026;448:113-127.
    PubMed    
    Abstract available

  158. GRIFFIOEN MS, Runello F, Steenbergen RDM
    DNA Methylation in Cervical Intraepithelial Neoplasia and Cervical Cancer: Triage and Management.
    Curr Top Microbiol Immunol. 2026;448:93-112.
    PubMed    
    Abstract available

  159. DILLNER J
    Human Papillomavirus Screening: Design and Targeting of Human Papillomavirus Genotypes.
    Curr Top Microbiol Immunol. 2026;448:81-92.
    PubMed    
    Abstract available

  160. ELLIS LB, Kyrgiou M, Moscicki AB
    Microbiome, Human Papillomavirus and Cervical Carcinogenesis.
    Curr Top Microbiol Immunol. 2026;448:59-80.
    PubMed    
    Abstract available

  161. DEL PINO M
    Cofactors in Human Papillomavirus Carcinogenesis.
    Curr Top Microbiol Immunol. 2026;448:39-58.
    PubMed    
    Abstract available

  162. POKA R
    [New data to the evolution of the surgical treatment of early-stage cervical cancer].
    Orv Hetil. 2026;167:251-256.
    PubMed    
    Abstract available

  163. SHI Y, Yao Y, He F, Chen X, et al
    Association of EGFR and EGF gene polymorphisms with cervical cancer in a case-control study and cross-cancer meta-analysis.
    Sci Rep. 2026 Feb 14. doi: 10.1038/s41598-026-38712.
    PubMed    
    Abstract available

  164. HE G, Qu X, Ding Z, Liang J, et al
    IGSF3 binds to TNFR2 on Treg to facilitate immunosuppression in cervical cancer.
    Cancer Lett. 2026 Feb 12:218307. doi: 10.1016/j.canlet.2026.218307.
    PubMed    
    Abstract available

  165. MEI J, Yang Z, Li M, Xiong C, et al
    The impact of illness perception on marital quality among patients with cervical cancer and their husbands: based on actor-partner interdependence mediation model.
    Eur J Oncol Nurs. 2026;81:103143.
    PubMed    
    Abstract available

  166. JIANG H, Zhu P, Chen Y, Xiong J, et al
    The Dual Role of DNA Methylation Test Can Optimize the Clinical Application of High-Risk Human Papillomavirus Testing in Detecting Cervical Intraepithelial Neoplasia Grade 3 or Worse.
    J Med Virol. 2026;98:e70836.
    PubMed    
    Abstract available

  167. SWANSON M, El Ayadi A, Nakalembe M, Namugga J, et al
    Predictors of delay in the cervical cancer care cascade in Kampala, Uganda.
    BMC Womens Health. 2026 Feb 13. doi: 10.1186/s12905-026-04292.
    PubMed    


  168. COLE G, Ali AA, McCrudden CM, McBride JW, et al
    Corrigendum to "DNA vaccination for cervical cancer: Strategic optimisation of RALA mediated gene delivery from a biodegradable microneedle system" [Eur. J. Pharm. Biopharm. 127 (2018) 288-297].
    Eur J Pharm Biopharm. 2026 Feb 12:115018. doi: 10.1016/j.ejpb.2026.115018.
    PubMed    


  169. LIU X, Wang A, Su M, Liang Z, et al
    ADARB1 inhibits glycolysis and progression of cervical cancer through the HMGB1/PFKFB3 axis.
    Biochim Biophys Acta Mol Basis Dis. 2026 Feb 11:168191.
    PubMed    
    Abstract available

  170. VINCZE A, Marai D, Frivaldszky L, Rancz A, et al
    Neoadjuvant chemotherapy enables fertility preservation without compromising oncologic outcomes in early cervical cancer >/=2 cm: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2026;52:111461.
    PubMed    
    Abstract available

  171. GUO Q, Wang H, Diao X, Liu Y, et al
    Utility of PAX1/JAM3 methylation analysis for triage of high-risk HPV-positive individuals.
    Lab Med. 2026;57:lmaf096.
    PubMed    
    Abstract available

  172. SNIADECKI M, Jaworek P, Regent B, Biernat W, et al
    Challenges in examining mentally Ill virgo intacta: a case of non-HPV cervical cancer and potential ovarian metastasis.
    Ginekol Pol. 2026 Feb 13. doi: 10.5603/gpl.106395.
    PubMed    


  173. ZHANG G, Wang L, Chen J, Wang J, et al
    LAG-3-associated CD8(+) T-cell dysfunction in the cervical cancer tumor microenvironment.
    Front Immunol. 2026;17:1750726.
    PubMed    
    Abstract available

  174. WANG Y, Xie Y, Fang Y, Sui B, et al
    Acupuncture combined with immunotherapy for recurrent and metastatic cervical cancer: a pilot RCT protocol.
    Front Oncol. 2026;16:1718170.
    PubMed    
    Abstract available

  175. MISHRA V, Pandey L, Pandey A, Chatterjee R, et al
    Evaluation of Interfraction Dose Discrepancies in Organs at Risk, Clinical Target Volume, and Points A and B in Computed Tomography-based High-dose-rate Intracavitary Brachytherapy for Cervical Cancer Patients.
    J Med Phys. 2025;50:709-713.
    PubMed    
    Abstract available

  176. DETWONGYA C, Tantipalakorn C, Charoenkwan K
    External validation of the SUCCOR Risk score for predicting recurrence in early-stage cervical cancer patients treated with radical hysterectomy.
    J Gynecol Oncol. 2026 Jan 27. doi: 10.3802/jgo.2026.
    PubMed    
    Abstract available

  177. MOLIKA P, Nittayaboon K, Kerdkumthong K, Navakanitworakul R, et al
    Mesenchymal Stem Cell-Derived Exosomes Reprogram Chemosensitivity Pathways in Cervical Cancer Spheroids.
    Int J Mol Sci. 2026;27:1575.
    PubMed    
    Abstract available

  178. SZTUKA M, Jelen A, Krygier A, Szmajda-Krygier D, et al
    The Epidemiology of Human Papillomavirus (HPV) Infections in Poland in the Light of the Nationwide HPV Vaccination Program for Children Aged 12-13 and Updated HPV DNA Detection Guidelines.
    Int J Mol Sci. 2026;27:1434.
    PubMed    
    Abstract available

  179. OLIVEIRA MHR, Aparicio SL, Silva JACD, Neto DAL, et al
    Barriers to Accessing Cervical Cancer Screening and Treatment in the Amazon Region-A Systematic Review.
    J Clin Med. 2026;15:1206.
    PubMed    
    Abstract available

  180. JOUYA S, Shahabinia Z, Mazidimoradi A, Allahqoli L, et al
    Cervical Cancer Epidemiology: Global Incidence, Mortality, Survival, Risk Factors, and Equity in HPV Screening and Vaccination.
    J Clin Med. 2026;15:1079.
    PubMed    
    Abstract available

  181. CHODICK G, Strassberg M
    Association Between Human Papillomavirus Vaccination and the Risk of Cervical Cancer and Precancerous Lesions in Israel: A Retrospective Cohort Study.
    J Clin Med. 2026;15:995.
    PubMed    
    Abstract available

  182. CHANUDOM I, Tharavichitkul E, Laosiritaworn W
    Survival Period Prediction in Cervical Cancer Patients Using the Selective Stacking Technique.
    Healthc Inform Res. 2026;32:38-49.
    PubMed    
    Abstract available

  183. ZHAO Q, Yang W, Cao L, Chen Y, et al
    Magnesium Ions Promote the Apoptosis of Cervical Cancer Cells through the PI3K/AKT/FoxO1 Pathway.
    Biol Trace Elem Res. 2026 Feb 13. doi: 10.1007/s12011-026-05014.
    PubMed    
    Abstract available

  184. BONALA SR, Raja SA, Subramanian BV, Balaraju S, et al
    Randomized comparison of tandem-ring versus tandem-ovoid applicators in volume-based brachytherapy for cervical cancer: Dosimetric analysis and early clinical outcomes.
    Brachytherapy. 2026 Feb 11:S1538-4721(25)00373.
    PubMed    
    Abstract available

  185. JACQUES LJ, Clarkson M, Humphrey PM
    Patient experiences of radiation-induced menopause in cervical cancer: A scoping review.
    Radiography (Lond). 2026;32:103345.
    PubMed    
    Abstract available

  186. CHEN J, Gu Y, Zheng Y, Gu M, et al
    FTO promotes the cervical cancer progression via regulation of FGF2 expression.
    Ann Med Surg (Lond). 2026;88:1359-1368.
    PubMed    
    Abstract available

  187. CHENG C, Yang Y, Qu Y
    Investigation of the impact of image-guided radiotherapy selection on image registration results and non-coding RNAs for cervical cancer patients.
    Noncoding RNA Res. 2025;18:87-91.
    PubMed    
    Abstract available

  188. QIU H, Shi Q, Tang T, Shen K, et al
    Feasibility study of U-Net-based automatic segmentation of pelvic bone marrow for postoperative radiotherapy in cervical cancer.
    Front Oncol. 2026;15:1612984.
    PubMed    
    Abstract available

  189. BALAMOU C, Zysman K, Rodrigue CM, Seigneurin A, et al
    Impact of commune level social inequalities on time to diagnosis and follow-up in women with high-grade cervical lesions in Isere, France: Evidence from the French cervical cancer screening program.
    Prev Med Rep. 2026;62:103396.
    PubMed    
    Abstract available

  190. YANG C, Li M, Yang C, Jiang P, et al
    Radiomics based on habitat analysis in predicting parametrial invasion of early stage cervical cancer.
    Front Oncol. 2026;16:1694347.
    PubMed    
    Abstract available

  191. CORBEAU A, Welters MJP, Boekestijn S, Mens JWM, et al
    Dynamic immune changes after bone marrow sparing VMAT in women with locally advanced cervical cancer treated with chemoradiotherapy.
    Clin Transl Radiat Oncol. 2026;58:101107.
    PubMed    
    Abstract available

  192. LU Y, Zhao J, Jia Z, Zhang C, et al
    Efficacy and safety of neoadjuvant chemotherapy combined with concurrent chemoradiotherapy and concurrent chemoradiotherapy alone in locally advanced cervical cancer: a systematic review and meta-analysis.
    Transl Cancer Res. 2026;15:17.
    PubMed    
    Abstract available

  193. WANG C, Zhu K, Bai L, Zhu X, et al
    Sodium selenite promotes apoptosis and augments autophagic flux in cervical cancer cells by activating the YAP-Hippo signaling pathway.
    Transl Cancer Res. 2026;15:36.
    PubMed    
    Abstract available

  194. MORADPANAH S, Rahimi S, Nayebzadeh M, Doosty F, et al
    Hydrogel-enhanced brachytherapy in cervical cancer: redefining precision, efficacy, and safety.
    Eur J Med Res. 2026 Feb 11. doi: 10.1186/s40001-026-03876.
    PubMed    
    Abstract available

  195. LIU J, Zhou L, Yao P, Zhang N, et al
    M(5)C-driven stabilization of SERPINB5 promotes cervical cancer progression and chemotherapy resistance.
    Cell Death Dis. 2026 Feb 11. doi: 10.1038/s41419-026-08453.
    PubMed    
    Abstract available

  196. MOODLEY J, Scott SE, Day S, Guzha BT, et al
    Time to diagnosis for breast, cervical and colorectal cancer in Zimbabwe and South Africa: a cross-sectional study.
    BMJ Glob Health. 2026;11:e021889.
    PubMed    
    Abstract available

  197. CHAE YK, Othus M, Patel SP, Backes FJ, et al
    DART/SWOG/NCI phase II anti-CTLA-4/PD-1 trial: clear cell carcinomas of ovary, endometrium, cervix.
    J Immunother Cancer. 2026;14:e012805.
    PubMed    
    Abstract available

  198. FLINT ML, Byrne ME, Friedman CF
    Locally Advanced Cervical Cancer: What is the Preferred Systemic Treatment?
    J Natl Compr Canc Netw. 2025;23:e257123.
    PubMed    
    Abstract available

  199. ABU-RUSTUM NR, Campos SM, Amarnath S, Arend R, et al
    Cervical Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.
    J Natl Compr Canc Netw. 2025;23:549-573.
    PubMed    
    Abstract available

  200. AKERELE OE, Olanrewaju AK
    Social Media Peer-Driven Communication on Cervical Cancer and HPV Vaccine Among Female Youth in Nigeria.
    J Cancer Educ. 2026 Feb 11. doi: 10.1007/s13187-025-02817.
    PubMed    
    Abstract available

  201. SUN P, Fan Z, Li L
    Comment on "Analysis of Quality, Reliability, and Content of Cervical Cancer-Related Chinese Videos on TikTok".
    J Cancer Educ. 2026 Feb 11. doi: 10.1007/s13187-026-02834.
    PubMed    


  202. SHAO D, Wu P, Jiang H, Wang Z, et al
    Global trends and future projections of cervical cancer burden: an integrated analysis of GBD 2021, UN population and WHO HPV vaccination data.
    Front Public Health. 2026;14:1702186.
    PubMed    
    Abstract available

  203. WANG F, Pang R, Zhang Y
    Efficacy and safety of neoadjuvant chemotherapy followed by radical surgery vs. radical surgery alone in locally advanced cervical cancer: A systematic review and meta-analysis.
    Biomed Rep. 2026;24:40.
    PubMed    
    Abstract available

  204. SHI H, Huang X, Yu J, Shan W, et al
    Precision management of cervical cancer emphasizes immunotherapy combination regimens and translational advances.
    Discov Oncol. 2026 Feb 11. doi: 10.1007/s12672-026-04588.
    PubMed    


  205. SILVA LGSD, Silva PVS, Chaves MFD, Oliveira NPD, et al
    Spatial distribution of timely treatment for cervical cancer: Socioeconomic inequalities and disparities in healthcare service availability in Brazil.
    Cancer Epidemiol. 2026;101:103010.
    PubMed    
    Abstract available

  206. QUINTERO-URIBE MP, Benavides-Lozano N, Campino-Alvarado T, Aguirre-Martinez MA, et al
    Role of Self-Sampling Devices for HPV Detection in Cervical Cancer Screening: A Systematic Review.
    J Low Genit Tract Dis. 2026 Feb 10. doi: 10.1097/LGT.0000000000000935.
    PubMed    
    Abstract available

  207. TIAN X, Li M, Wang Z, Fang T, et al
    Proteogenomic characterization of cervical cancer identifies molecular subtypes predictive of clinical outcomes and subtype-specific targets.
    J Clin Invest. 2026 Feb 10:e199497. doi: 10.1172/JCI199497.
    PubMed    
    Abstract available

  208. BAVOR C, Jennett C, Phillips E, Mitchell L, et al
    How would Australian women and people with a cervix like to access self-collection for cervical screening? Screening preferences from a national survey.
    Cancer Causes Control. 2026;37:47.
    PubMed    
    Abstract available

  209. PASSARELLI GV, Whang SN, Gilbert NM, Hu J, et al
    The vaginal microbiome, papillomavirus infection, and cervical cancer: established associations in search of model systems and mechanistic answers.
    mBio. 2026 Feb 10:e0267725. doi: 10.1128/mbio.02677.
    PubMed    
    Abstract available

  210. WANG X, Zheng X, Fang Y, Zheng T, et al
    The promoting role of protein arginine methyltransferase 1 in cervical cancer: Mechanisms of angiogenesis and immune evasion.
    Cytojournal. 2025;22:104.
    PubMed    
    Abstract available

  211. NAMUTUNDU J, Nakalembe M, Nakku-Joloba E, Kiguli J, et al
    Integrating the behavior change wheel and co-design approach in selecting strategies for improving cervical cancer screening literacy among rural women living with HIV in Eastern Uganda.
    BMC Health Serv Res. 2026 Feb 9. doi: 10.1186/s12913-026-14152.
    PubMed    


  212. MIN S, Xie L, Wu Y, Bo L, et al
    Efficacy of FOXP3+Treg cells combined with platelet in predicting recurrence of cervical cancer: a retrospective study.
    BMC Womens Health. 2026 Feb 9. doi: 10.1186/s12905-026-04274.
    PubMed    


  213. WU H, He C, Liu M, Zhao X, et al
    Impact of rectal gas evacuation on dosimetry and applicator displacement in cervical cancer brachytherapy.
    J Appl Clin Med Phys. 2026;27:e70490.
    PubMed    
    Abstract available

  214. GGINGO S, Obore S, Musaba M, Wandabwa J, et al
    Factors Associated with Human Papillomavirus Vaccination Uptake Among Adolescent Girls in Uganda.
    Am J Trop Med Hyg. 2025;114:355-359.
    PubMed    
    Abstract available

  215. GUAN J, Liu H, Li J, Chang Z, et al
    Cervical HPV in central China: regional prevalence, subtypes and pathology.
    J Infect Dev Ctries. 2026;20:129-133.
    PubMed    
    Abstract available

  216. BAO YH, Chen Y, Xiao ML, Li YA, et al
    Primary tumor-derived, multiparametric MRI-based deep learning-radiomics-clinical model for predicting lymph node metastasis in early-stage cervical cancer.
    Insights Imaging. 2026;17:38.
    PubMed    
    Abstract available

  217. WINARTO H, Glenardi G, Habiburrahman M, Kusuma F, et al
    Exploring Knowledge, Attitudes, Practices, and Information-Seeking on HPV Infection and Cervical Cancer Prevention in Rural Indonesia.
    Asian Pac J Cancer Prev. 2026;27:693-704.
    PubMed    
    Abstract available

  218. DAS D, Sepai HM, Pal SK, Chakraborty BC, et al
    An Altered Ratio of CD4+ and CD8+ T Lymphocytes in Cervical Cancer Tissue and Peripheral Blood as a Predictor of Prognostic Outcome: A Clinicopathological Study.
    Asian Pac J Cancer Prev. 2026;27:643-649.
    PubMed    
    Abstract available

  219. RAY A, Karmakar A, Maiti M, Banerjee S, et al
    Evaluation of the Diagnostic Accuracy of Cervical Cell Morphologies from Android Device-Captured Cytopathological Microscopic Images through Artificial Intelligence in Mainly Rural or Resource-Constraint Areas of India.
    Asian Pac J Cancer Prev. 2026;27:601-612.
    PubMed    
    Abstract available

  220. DARTIBALE CB, De Souza MVF, Prado GC, Sant'Ana DMG, et al
    Performance of a New Brazilian Self-Sampling Device for High-Risk Human Papillomavirus Screening.
    Asian Pac J Cancer Prev. 2026;27:405-409.
    PubMed    
    Abstract available

  221. WANG X, Pan X, Li X, Ding B, et al
    Epithelial Cell-Specific Prognostic Signature (FTH1, RIT1, WASL, NDRG2, KIFC3) Stratifies Cervical Cancer Patients and Correlates With Immune Infiltration.
    Hum Mutat. 2026;2026:4109928.
    PubMed    
    Abstract available

  222. ALGHANMI R, Alkhalawi E, Albeladi R, Albeladi S, et al
    Parental Knowledge and Acceptance of HPV Vaccine in Rabigh's School, Saudi Arabia.
    Ann Glob Health. 2026;92:13.
    PubMed    
    Abstract available

  223. JOHNSON M, Joy TM, Rasheed A, Rose BM, et al
    Cervical Cancer Screening Among Rural Women in Ernakulam District, Kerala: A Cross-Sectional Study.
    Cureus. 2026;18:e100961.
    PubMed    
    Abstract available

  224. WANG Z, Liu H, Chen X, Zhang F, et al
    Comparative predictive performance of three machine learning algorithms for acute radiation enteritis risk among patients with cervical cancer undergoing radiotherapy: A prospective cohort study.
    Asia Pac J Oncol Nurs. 2026;13:100853.
    PubMed    
    Abstract available

  225. JIANG K, Shao Y, Wang H, Zhao F, et al
    HPV vaccination willingness and behavior among patients with cervical intraepithelial neoplasia in low-resource areas of Western China: a cross-sectional study.
    Front Public Health. 2026;13:1708917.
    PubMed    
    Abstract available

  226. JOSEPH EA, Mula M, Mehdi Khan MM, Allen CJ, et al
    Assessing long-term quality of life and survivorship priorities in cervical cancer patients: a social media survey-based study.
    Gynecol Oncol Rep. 2026;63:102031.
    PubMed    
    Abstract available

  227. WANG H, Xu S, Li S, Lin M, et al
    TMEM121 suppresses cervical cancer cell proliferation and migration via interaction with the ERK pathway.
    Am J Cancer Res. 2026;16:70-87.
    PubMed    
    Abstract available

  228. NISHIZAWA N, Ishikawa M, Maskey MR, Esumi A, et al
    Circularly polarized light scattering imaging of a cancerous layer creeping under a healthy layer for the diagnosis of early-stage cervical cancer.
    J Biomed Opt. 2026;31:027002.
    PubMed    
    Abstract available

  229. BEREZOWITZ JD, Fish MC, Mehanna LE, Knicely B, et al
    Tiny plastic, big trouble: how polystyrene nanoparticles impact DNA-damage repair deficient cervical cancer cells.
    Soft Matter. 2026 Feb 9. doi: 10.1039/d5sm01095.
    PubMed    
    Abstract available

  230. VANAN AG, Hassanzadeh F, Ghorbaninezhad F, Taheri F, et al
    LncRNA CCAT2 role in female-related cancer progression and diagnosis: a comprehensive review.
    Clin Exp Med. 2026;26:130.
    PubMed    
    Abstract available

  231. JIT M
    Human papillomavirus, human immunodeficiency virus, and the shared road to cervical cancer elimination.
    J Natl Cancer Inst. 2026 Feb 6:djag017. doi: 10.1093.
    PubMed    


  232. WIWEKANANDA IGNA, Malek NANN, Endharti AT, Permatasari HK, et al
    Nab-paclitaxel for the treatment of cervical cancer: a systematic review of clinical safety and effectiveness.
    J Chemother. 2026 Feb 8:1-13. doi: 10.1080/1120009X.2026.2625548.
    PubMed    
    Abstract available


  233. RETRACTION: Epigallocatechin Gallate in Combination With Eugenol or Amarogentin Shows Synergistic Chemotherapeutic Potential in Cervical Cancer Cell Line.
    J Cell Physiol. 2026;241:e70143.
    PubMed    
    Abstract available

  234. ZHANG Y, Shao Y, Li X, Zhou D, et al
    SREBF2 enhances lipid metabolism and represses anti-tumor immune responses in cervical cancer by increasing ACAT2.
    Commun Biol. 2026 Feb 7. doi: 10.1038/s42003-026-09678.
    PubMed    
    Abstract available

  235. XIAO C, Wang L, Xia C, Chan PKS, et al
    HPV18E6 and CDK5 virus-host interaction is a prospective therapeutic target for HPV-positive cervical cancer.
    Tumour Virus Res. 2026;21:200339.
    PubMed    
    Abstract available

  236. WU X, Li Y, Zheng Z, Hu J, et al
    Site-specific propynylation modification of apigeninidin enhances anti-cervical cancer activity by targeting PARP-1.
    Bioorg Chem. 2026;172:109600.
    PubMed    
    Abstract available

  237. HUANG J, Wu S, Wang X, Lin H, et al
    NIR Triggered Fluorescence Imaging and Synergistic Ablation of Cervical Cancer Using ICG-Loaded CuO Nanoleaves via Photothermal-Augmented ROS Amplification.
    ACS Appl Bio Mater. 2026 Feb 7. doi: 10.1021/acsabm.5c02472.
    PubMed    
    Abstract available

  238. LIU J, Wang A, Wang G, Jiang S, et al
    Gallium-enriched bimetallic nanomedicine for cervical tumour suppression via bioimaging-guided surgery and highly synergistic reactive oxygen species burst.
    J Colloid Interface Sci. 2026;709:139952.
    PubMed    
    Abstract available

  239. ZHAO C, Li M, Chen R, Zhao Y, et al
    Comparison of different mRNA testing technologies with HPV DNA testing for predicting ASCUS triage and post-cone excision outcomes: a systematic review and meta-analysis.
    Syst Rev. 2026;15:53.
    PubMed    
    Abstract available

  240. TAN Y, Huang Q, Zeng J, Wang Y, et al
    Transient receptor potential canonical 3 is required for HPV-induced malignant transformation of cervical epithelial cells.
    Commun Biol. 2026;9:204.
    PubMed    
    Abstract available

  241. MANJESHWAR S, Kojima N, Tsang E, Pereira D, et al
    Performance of a novel, urine-based test for the detection of cervical human papillomavirus infection.
    J Clin Microbiol. 2026;64:e0131825.
    PubMed    
    Abstract available

  242. MA M, Luo F, Ma B, Liu S, et al
    A Multi-instance Learning Network with Prototype-instance Adversarial Contrastive for Cervix Pathology Grading.
    Med Image Anal. 2026;109:103880.
    PubMed    
    Abstract available

  243. RAKE C, Davidson EJ, Young A, Maskell A, et al
    The Use of First-Void Urine to Screen Women Aged 60-79 for HPV in the UK: The Catch-Up Screen Study.
    BJOG. 2026;133:814-822.
    PubMed    
    Abstract available

  244. LUAN Y, Zhu Y, Sun L, Qin F, et al
    MRI quantitative parameters combined with pathological microvascular characteristics predict lymph node metastasis of cervical squamous cell carcinoma.
    Acta Radiol. 2026;67:188-198.
    PubMed    
    Abstract available

  245. JIN Q, Zhang X, Yuan J, Fang Q, et al
    Breaking New Ground in Cervical Metastatic Carcinoma of Unknown Primary: Neoadjuvant Immunochemotherapy's Pathologic Regression and Survival Advantage.
    Ann Surg Oncol. 2026;33:2493-2502.
    PubMed    
    Abstract available

  246. LA FRINERE-SANDOVAL NQNB, Cubbin C, DiNitto DM
    The Association between Binge Drinking and Mammography and Pap Test Screening by Women's Race and Ethnicity.
    J Womens Health (Larchmt). 2026;35:306-317.
    PubMed    
    Abstract available

  247. XU R, Liu H, Zhu T, Tang H, et al
    An immunosuppressive tertiary lymphoid structure is associated with adverse prognosis in gastric-type endocervical adenocarcinoma.
    J Natl Cancer Inst. 2026;118:276-288.
    PubMed    
    Abstract available

  248. HOWARD MF, Fyffe-Freil RC, Pierre CC, Maku HO, et al
    Self-collection for primary HPV screening using dry swabs: a review of clinical performance, laboratory considerations, and patient preferences.
    J Clin Microbiol. 2025 Oct 21:e0076724. doi: 10.1128/jcm.00767.
    PubMed    
    Abstract available

  249. ZHANG X, Wang J, Ke G, Zhang Y, et al
    Self-management experiences of vaginal toxicities among patients undergoing radical radiotherapy for cervical cancer: a qualitative study.
    BMC Womens Health. 2026 Feb 21. doi: 10.1186/s12905-026-04343.
    PubMed    


  250. LAMICHHANE A, Kaphle HP, Neupane N, Baral S, et al
    Factors associated with cervical cancer screening uptake among women aged 30-49 years of Bhanu Municipality, Tanahun, Nepal: a cross-sectional study.
    BMC Womens Health. 2026 Feb 21. doi: 10.1186/s12905-026-04360.
    PubMed    


  251. LAAS E, Gaillard T, Fourchotte V, Hotton J, et al
    [Cervical cancer with SHAPE criteria: Conisation before simple hysterectomy].
    Bull Cancer. 2026 Feb 19:S0007-4551(26)00101.
    PubMed    


  252. YOUNG AP, O'Dwyer MC, Smith R, Saunders N, et al
    Kennedy v Braidwood Ruling Affects Women and Cervical Cancer Screening.
    J Am Board Fam Med. 2025;38:1113-1116.
    PubMed    
    Abstract available

  253. LEJEUNE CL, Van Calsteren K, Baert T, Vandecaveye V, et al
    A multidisciplinary management approach to cervical cancer during pregnancy.
    Lancet. 2026 Feb 17:S0140-6736(26)00190-X. doi: 10.1016/S0140-6736(26)00190.
    PubMed    


  254. VIDAURRE MENDES S, Kischinhevsky DG, Lopes da Silva J, Dos Santos ALS, et al
    Epidemiology of Cervical Cancer in Brazil: Age-Specific Trends From 2000 to 2018.
    JCO Glob Oncol. 2026;12:e2500416.
    PubMed    
    Abstract available

  255. VEERAVAGU T, Hamdiui N, Stein ML, Al-Rubaie N, et al
    Supporting Informed Decision-Making Regarding Participation in Cervical Cancer Prevention Programs: A Qualitative Study Among Turkish-, Moroccan-, and Syrian-Dutch Women.
    Community Health Equity Res Policy. 2026 Feb 20:2752535X261427045.
    PubMed    
    Abstract available

  256. ZHONG M, Peitz J, Newman M, Yussuf S, et al
    Novel circRNA signatures in cervical cancer: implications for early detection and screening.
    Biomark Med. 2026 Feb 19:1-10. doi: 10.1080/17520363.2026.2631965.
    PubMed    
    Abstract available

  257. CHIGBU CO, Dim CC, Eneh SC, Olakunde BO, et al
    Cervical cancer screen-and-treat services at HIV treatment sites in Nigeria: findings from the ICON-3 Practice Based Research Network.
    BMC Health Serv Res. 2026 Feb 20. doi: 10.1186/s12913-026-14167.
    PubMed    


  258. ZHAO X, Huang Y, Lv Q, Wang L, et al
    Awareness of cervical cancer and its correlates among junior high school students in Eastern China: a cross sectional study.
    BMC Public Health. 2026 Feb 20. doi: 10.1186/s12889-026-26748.
    PubMed    


  259. ANAND KV, Mishra GA, Suryawanshi VB, Pimple SA, et al
    Experiences with HPV self-sampling in India: advancing cervical cancer prevention and screening.
    BMC Public Health. 2026 Feb 19. doi: 10.1186/s12889-026-26212.
    PubMed    


  260. LIN J, Lin M, Lin L, Chen Q, et al
    Single-Cell Sequencing Combined with RNA Sequencing Reveals the Role of Natural Killer Cells in Prognosis and Immunotherapy Response in Cervical Squamous Cell Carcinoma.
    Crit Rev Immunol. 2026;46:27-43.
    PubMed    
    Abstract available

  261. ROWLINSON E, Snih SA
    Factors associated with mammogram and Papanicolaou testing among Mexican American older women.
    Womens Health (Lond). 2026;22:17455057261421727.
    PubMed    
    Abstract available

  262. CHEN J, Mo Z, Pan J, Jia L, et al
    Automated gross tumour volume delineation on T2-weighted magnetic resonance imaging coupled with radiomics for predicting cervical cancer recurrence.
    Eur J Med Res. 2026 Feb 18. doi: 10.1186/s40001-025-03777.
    PubMed    
    Abstract available

  263. AMUBUOMOMBE PP, Itsura P, Tonui PK, Orang'o EO, et al
    Pregnancy outcomes among women with and without HIV infections who underwent excisional treatment for high-grade cervical intraepithelial neoplasia: a retrospective cohort study in low-resource settings.
    BMJ Open. 2026;16:e105559.
    PubMed    
    Abstract available

  264. AGUSTI N, Viveros-Carreno D, Wu CF, Iniesta MD, et al
    Survival Outcomes After Inadvertent Surgery in Low-Risk Early-Stage Cervical Cancer.
    Am J Obstet Gynecol. 2026 Feb 16:S0002-9378(26)00081.
    PubMed    
    Abstract available

  265. RICARDO MG, Alberto MG, Maria HA, Ramos, et al
    PD-L1 expression in cervical cancer tissue is strongly associated with the expression of CD73/TGF-beta1, the percentage of CD8+/PD-1+ T cells and disease progression.
    Immunol Lett. 2026 Feb 16:107150. doi: 10.1016/j.imlet.2026.107150.
    PubMed    
    Abstract available

  266. ZHANG X, Tao X, Bao K
    Comparative analysis of trends and projections of cervical cancer burden among women aged 20-64 years in China, Japan, and South Korea, 1990-2050.
    Discov Oncol. 2026 Feb 18. doi: 10.1007/s12672-026-04688.
    PubMed    
    Abstract available

  267. MILERAD H, Bonander C, Nordqvist Kleppe S, Dillner J, et al
    [Geomapping of 10-year coverage rate of cervical cancer screening in Sweden - a basis for targeting population-level interventions to improve screening].
    Lakartidningen. 2026;123:25052.
    PubMed    
    Abstract available

  268. CHENG X, Wang J, Wang H, Song H, et al
    Case Report: A rare case of external iliac artery rupture and sigmoid fistula following multimodal treatment for cervical cancer.
    Front Oncol. 2026;16:1708443.
    PubMed    
    Abstract available

  269. GOMES P, de Abreu WC, Dos Reis RG, Guerra ENS, et al
    Photobiomodulation therapy approach to a rare phenomenon of radiation recall reaction triggered by cisplatin in a cervical cancer patient: a case report and scoping review.
    Front Oncol. 2026;15:1700942.
    PubMed    
    Abstract available

  270. THARAVICHITKUL E, Chitapanarux I, Sripan P, Tovanabutra C, et al
    Unlocking economic gains: the impact of image-guided brachytherapy on cervical cancer treatment in Thailand.
    Front Public Health. 2026;13:1725415.
    PubMed    
    Abstract available

  271. MENG X, Wang Z, Zhang Y, Wang X, et al
    RapidArc Dynamic (RAD) multi-mechanical axis optimization achieves enhanced OAR sparing in cervical cancer: A dosimetric comparison study.
    J Appl Clin Med Phys. 2026;27:e70506.
    PubMed    
    Abstract available

  272. WENTZENSEN N, Egemen D, Clarke MA, Poitras N, et al
    Long-Term Prospective Cohort Study of Cervical Cancer Screening Using Triage of Women who Are Human Papillomavirus-Positive With Dual Stain and Human Papillomavirus Genotyping.
    J Clin Oncol. 2026 Feb 17:JCO2500689. doi: 10.1200/JCO-25-00689.
    PubMed    
    Abstract available

  273. OGUNDARE OC, Adeyemo GO, Folorunsho S
    Determinants of cervical cancer screening among African and African American women: a qualitative systematic review.
    Ethn Health. 2026 Feb 17:1-16. doi: 10.1080/13557858.2026.2630820.
    PubMed    
    Abstract available

  274. LIU Y, Wang S, Gao S
    Human Papillomavirus (HPV) Type Distribution in Cervical Carcinoma, Low-Grade, and High-Grade Squamous Intraepithelial Lesions in Women Under 25 Years Old From the Largest Women Hospital in China.
    J Med Virol. 2026;98:e70846.
    PubMed    
    Abstract available

  275. WANG Z, Wang Z, Jiang J, Yang L, et al
    Reprogramming the tumor immune microenvironment in cervical cancer: synergy between radiotherapy and immunotherapy.
    Mol Cancer. 2026 Feb 17. doi: 10.1186/s12943-026-02600.
    PubMed    


  276. SOLTANI LF, Addis I, Lin P, Kamdar N, et al
    Characterizing Cervical Cancer Screening in the US: Preparing for the Era of Self-Collection.
    J Am Board Fam Med. 2026 Feb 16. doi: 10.3122/jabfm.2025.250040.
    PubMed    
    Abstract available

  277. YANG Q, Zhao J, Liu X, Liu J, et al
    Identification and mechanistic exploration of VEGFA and CALML3 as calcium channel-related prognostic genes in cervical cancer.
    Discov Oncol. 2026 Feb 16. doi: 10.1007/s12672-026-04683.
    PubMed    


  278. LI Y, Wang F, Fang Z, Sun H, et al
    MUL1 suppresses cervical cancer progression by targeting FUNDC1 for ubiquitination and inhibiting DRP1-dependent mitophagy.
    J Mol Histol. 2026;57:79.
    PubMed    
    Abstract available

  279. ALMASABI SHA, Almasoudi HH, Albargy H, Alabbas MMA, et al
    Retraction Note: Alternative use of Droxidopa for treating cervical cancer: inhibiting transferase, cell cycle signalling, and transport proteins via multitarget docking, DFT, MD simulations, and binding free energy studies.
    Med Oncol. 2026;43:150.
    PubMed    


  280. SINGH A, Sahani P, Singh S, Ojha A, et al
    Role of human papillomavirus (HPV) variants and host genetic susceptibility in cervical carcinogenesis.
    Arch Microbiol. 2026;208:198.
    PubMed    
    Abstract available

  281. WANG B, Xiao J, Ding Y, Yu J, et al
    Preoperative prediction of parametrial invasion in early-stage cervical cancer: a radiomics nomogram fusing multi-parametric MRI and clinical biomarkers.
    Abdom Radiol (NY). 2026 Feb 16. doi: 10.1007/s00261-025-05353.
    PubMed    
    Abstract available

  282. KIBONIRE RA, Mphuthi DD
    Understanding the determinants of cervical cancer screening uptake in Hoima District, Uganda.
    Afr J Reprod Health. 2026;30:104-113.
    PubMed    
    Abstract available

  283. LI D
    Influence of gemcitabine combined with lobaplatin interventional embolization on vaginal flora and biofilm formation in patients with advanced cervical cancer.
    Afr J Reprod Health. 2026;30:38-50.
    PubMed    
    Abstract available

  284. WANG Z, Zhang Y, Xiu Y, Chen Z, et al
    Au-PtNPs@Mn(3)O(4) Nanozymes Enhance the Antitumor Effect of Photodynamic Therapy and Radiotherapy in Cervical Cancer by Modulating Tumor Hypoxia.
    ACS Omega. 2026;11:8183-8196.
    PubMed    
    Abstract available

  285. YORKE AA, Muramuzi A, Lin LL, Awusa K, et al
    Quantifying cervical cancer radiotherapy care gap: Baseline assessment prior to implementation of a digital Health App.
    Tech Innov Patient Support Radiat Oncol. 2026;37:100381.
    PubMed    
    Abstract available

  286. RAY S, Nagar A
    Educational intervention and its effect on medical students' knowledge and readiness for cervical cancer screening and human papillomavirus vaccination.
    J Family Community Med. 2026;33:53-54.
    PubMed    


  287. WANG X, Xiong D, Duan B, Huang Y, et al
    Mechanistic pathways predictive modeling and translational interventions for radiation enteritis in cervical cancer radiotherapy.
    Front Cell Infect Microbiol. 2026;15:1729528.
    PubMed    
    Abstract available

  288. MUNE G, Asefa A, Chillo SL, Woldesemayat EM, et al
    Cervical Cancer Screening and Associated Factors Among Women of Reproductive Age in Sidama Regional State of Ethiopia: A Cross-Sectional Survey.
    Cancer Rep (Hoboken). 2026;9:e70498.
    PubMed    
    Abstract available

  289. ZHANG T, Choon Park D, Jeong Jeong Y, Geun Yeo S, et al
    Screening of cervical intraepithelial neoplasia based on multiple features extracted from multi-electrode bioimpedance spectroscopy.
    Physiol Meas. 2026;47.
    PubMed    
    Abstract available

  290. POPOVIC J, Hahut A, Torres GE, Vincent A, et al
    Changes in EGFR activity following CRISPR/Cas9-editing of the EGF binding domain.
    Sci Rep. 2026;16:6797.
    PubMed    
    Abstract available

  291. LI X, Sun L, Qiu M, Wu X, et al
    Investigation of thoracico-abdominal infrared thermal imaging characteristics in patients with cervical HR-HPV infection.
    Sci Rep. 2026;16:6500.
    PubMed    
    Abstract available

  292. STUART R, Theopold N, Miall N, Kobayashi E, et al
    The role of HPV single-dose vaccination in expanding access in GAVI-supported countries during a period of supply constraints.
    Vaccine. 2026;75:128187.
    PubMed    
    Abstract available

  293. ZOU R, Xu J, Fang Q, Guan R, et al
    A novel cervical image recognition framework based on feature cognitive enhancement for improved performance.
    Proc Inst Mech Eng H. 2026;240:192-205.
    PubMed    
    Abstract available

  294. CHEN Q, Quan J, Zhu K, Lan L, et al
    Variations in the Natural History of High-Risk HPV Types Following HPV-16/18 Bivalent Vaccination in Females Aged 18-45 Years.
    Nat Commun. 2026;17:1677.
    PubMed    
    Abstract available

  295. XIA D, Gao Z, Li J, Chen C, et al
    pH-Responsive Biomineralized Probiotic for Self-Amplifying Mucosal Vaccination: Gut-Engineered Antigen Factories Drive Targeted Cervical Tumor Regression.
    Adv Mater. 2026;38:e10404.
    PubMed    
    Abstract available

  296. KOIVISTO T, Kalliala I, Eriksson T, Nieminen P, et al
    Human papillomavirus vaccinations' impact on preterm birth rates.
    Eur J Public Health. 2026;36:214-219.
    PubMed    
    Abstract available

  297. MUKEREBE C, Cordeiro AA, Aristide C, Colombe S, et al
    Schistosome Infection is Associated with High-Risk Human Papillomavirus Persistence, Together with Altered Cervicovaginal Microbiota.
    J Infect Dis. 2025 Aug 22:jiaf447. doi: 10.1093.
    PubMed    
    Abstract available

  298. CULLIMORE V, Newhouse R, Baker-Rand H, Chu K, et al
    Investigating the acceptability of cervical screening, using conventional clinician-taken cervical samples or urine self-sampling, at 6 weeks postnatal: A cross-sectional questionnaire.
    J Med Screen. 2026;33:48-58.
    PubMed    
    Abstract available

  299. FITZPATRICK P, O'Flynn A, Jalal R, Frazer K, et al
    Identifying barriers and facilitators to participation in cancer screening among Irish travellers, a minority ethnic group in Ireland, using a codesigned approach.
    J Med Screen. 2026;33:9-14.
    PubMed    
    Abstract available

  300. FUJITA M, Nagashima K, Shimazu M, Suzuki M, et al
    Ripple effect of temporary self-sampling HPV test on screening uptake in the next round: A secondary analysis of the ACCESS randomized controlled trial.
    J Med Screen. 2026;33:62-65.
    PubMed    
    Abstract available

  301. GAO J, Yang R, Lu R, Ma X, et al
    Current status and influencing factors of different dimensions of HPV knowledge among HPV-infected women.
    J Health Psychol. 2026;31:536-549.
    PubMed    
    Abstract available

  302. KANG M, Jiang S, Chen H, Xu Y, et al
    Prediction of the Prognosis and Treatment Responses Based on the Characteristics of Disulfidptosis-Related Genes in Patients with Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
    Endocr Metab Immune Disord Drug Targets. 2026;26:e18715303374396.
    PubMed    
    Abstract available

  303. HARINATH L, Bai X, Minkowitz J, Zeng X, et al
    Artificial Intelligence in Gynecologic Cytology.
    Acta Cytol. 2026;70:52-71.
    PubMed    
    Abstract available

  304. KHOLOVA I
    Not Enough Cells: How Insufficient Cytological Specimens Are Mirrored by Reporting Systems - Journey from the Bethesda to the WHO Reporting Systems.
    Acta Cytol. 2026;70:72-83.
    PubMed    
    Abstract available

  305. EDVARDSSON H, Dillner J
    Human Papillomavirus Primary Screening and Collaboration in Quality Assurance Work between Laboratories.
    Acta Cytol. 2026;70:46-51.
    PubMed    
    Abstract available

  306. LONGATTO-FILHO A, Schmitt FC
    Ongoing Challenges in Maintaining the Diagnostic Quality of Cervical Cytopathology: Is It Possible to Minimize Differences in Morphological Interpretations?
    Acta Cytol. 2026;70:40-45.
    PubMed    
    Abstract available

  307. ERIKSEN DO, Krog L, Ostenfeld EB, Jensen PT, et al
    HPV vaccination following cervical intraepithelial neoplasia grade 2 diagnosis and risk of progression.
    Acta Obstet Gynecol Scand. 2026;105:377-385.
    PubMed    
    Abstract available

  308. KALLIALA I, Milerad H, Trope AEC, Hammer A, et al
    Why do the Nordic countries allow colposcopy to be a weak link in the cervical cancer screening chain?
    Acta Obstet Gynecol Scand. 2026 Feb 17. doi: 10.1111/aogs.70166.
    PubMed    


  309. TAMRAKAR VK, Sharma K, Singh P, Bhargava A, et al
    Cervical cancer elimination in India: Repurposing diagnostics, vaccination, and accelerating policy for the 2030 target.
    Cancer. 2026;132:e70292.
    PubMed    
    Abstract available

  310. BONLOKKE S, Stougaard M, Sorensen BS, Parner E, et al
    Ultrasensitive next-generation sequencing-based detection of circulating human papillomavirus DNA for cervical cancer recurrence monitoring.
    Cancer. 2026;132:e70282.
    PubMed    
    Abstract available

  311. OZDEMIR CY, Marangoz B, Ozdemir N, Cicekli N, et al
    Clinical Outcomes and Risk Implications of HPV 31 Infection: A 10-Year Retrospective Cohort Study.
    Diagn Cytopathol. 2026;54:167-172.
    PubMed    
    Abstract available

  312. HARINATH L, Matsko J, Colaizzi A, Elishaev E, et al
    Morphologic Evaluation of Hyperchromatic Crowded Groups Present in Cervical Thin Prep Cytology Tests as Identified by the Hologic Genius Digital Diagnostics System: A Descriptive Study.
    Diagn Cytopathol. 2026;54:173-183.
    PubMed    
    Abstract available

  313. ANAND A, Mala YM, Tyagi S, Sharma P, et al
    Knowledge, awareness and practices regarding human papillomavirus vaccine amongst secondary school girls and mothers in North India.
    Eur J Obstet Gynecol Reprod Biol. 2026;318:114945.
    PubMed    
    Abstract available

  314. DAIX-MOREUX M, El Hajj H, Scherier S, Deandreis D, et al
    Para-aortic lymphadenectomy after negative PET-CT in locally advanced cervical cancer: a continuous monocentric series of 320 cases.
    Gynecol Oncol. 2026;206:99-105.
    PubMed    
    Abstract available

  315. REDL E, Herzog C, Vavourakis C, Barrett J, et al
    The cervico-vaginal DNA methylation WID-qEC test: An epigenetic marker associated with ovarian cancer in the absence of endometrial and cervical cancer.
    Int J Cancer. 2026 Jan 29. doi: 10.1002/ijc.70354.
    PubMed    
    Abstract available

  316. KROON KR, Bogaards JA, Berkhof J
    Cost-effectiveness analysis of human papillomavirus (HPV) genotyping strategies for management of HPV-positive women in cervical cancer screening.
    Int J Cancer. 2026 Jan 28. doi: 10.1002/ijc.70344.
    PubMed    
    Abstract available

  317. GIES S, Pohlers M, Tanzer T, Ampofo E, et al
    Th17 cells favor migration and invasiveness of cervical cancer cells under hypoxia in an IGF2BP2-dependent manner.
    Int J Cancer. 2026 Jan 24. doi: 10.1002/ijc.70340.
    PubMed    
    Abstract available

  318. NOMM O, Innos K, Jasilionis D, Krumins J, et al
    Educational inequalities in cervical cancer mortality in the Baltic countries and Finland in the context of organized screening: A register-based study 2000-2015.
    Int J Cancer. 2026 Jan 24. doi: 10.1002/ijc.70339.
    PubMed    
    Abstract available

  319. RASMUSSEN RMW, Munk C, Kjaer SK
    Is the beneficial effect of multi-cohort HPV vaccination on cervical cancer and precancerous lesions seen across all educational levels?
    Int J Cancer. 2026 Feb 6. doi: 10.1002/ijc.70360.
    PubMed    
    Abstract available

  320. DE CARVALHO TM, Berkhof J, Bogaards JA
    Cost-effectiveness of risk-stratified screening for cervical cancer in cohorts vaccinated against human papillomavirus with moderate vaccination coverage.
    Int J Cancer. 2026 Feb 9. doi: 10.1002/ijc.70377.
    PubMed    
    Abstract available

  321. SNELLMAN J, Pankakoski M, Heinavaara S, Partanen VM, et al
    Increased cervical cancer incidence in the target age of screening-Variation by mode of detection.
    Int J Cancer. 2026 Feb 7. doi: 10.1002/ijc.70371.
    PubMed    
    Abstract available

  322. HOFFMANN S, Trif L, Kramer B, Neis F, et al
    PelviSound L-Real-time intraoperative sonographic assessment of pelvic sentinel lymph nodes using a drop-in probe in endometrial and cervical cancer during minimally invasive surgery: A single-center pilot feasibility study in 20 patients.
    Int J Gynaecol Obstet. 2026 Jan 29. doi: 10.1002/ijgo.70838.
    PubMed    
    Abstract available

  323. HU Y, Cheng H, Chen J, Chen S, et al
    Neoadjuvant chemotherapy plus cadonilimab followed by extra-fascial hysterectomy for International Federation of Gynecology and Obstetrics stage IB2 cervical cancer: a prospective, multi-center, single-arm, phase 2 trial.
    Int J Gynecol Cancer. 2026 Jan 5:104457. doi: 10.1016/j.ijgc.2025.104457.
    PubMed    
    Abstract available

  324. SEO JH, Chung YE, Lim S, Kim SY, et al
    Pre-diagnostic physical activity and mortality in cervical cancer: a nationwide cohort study.
    Int J Gynecol Cancer. 2026 Jan 16:104477. doi: 10.1016/j.ijgc.2026.104477.
    PubMed    
    Abstract available

  325. CIANCIA M, Moro F, Mascilini F, Testa AC, et al
    Response to the Correspondence by Peng et al. on "Diagnostic performance of ultrasound-guided biopsy for detecting recurrent or persistent cervical cancer after chemoradiotherapy: a prospective, single-center study" by Mascilini et al.
    Int J Gynecol Cancer. 2026 Jan 18:104499. doi: 10.1016/j.ijgc.2026.104499.
    PubMed    


  326. YONEMORI K, Nishio S, Suzuki S, Hasegawa K, et al
    Tisotumab vedotin in Japanese patients with recurrent or metastatic cervical cancer: results from the innovaTV 301/ENGOT-cx12/GOG-3057 trial.
    Int J Gynecol Cancer. 2025 Dec 31:104450. doi: 10.1016/j.ijgc.2025.104450.
    PubMed    
    Abstract available

  327. HEMIDA R, Barakat R, Nabil H, Hasan M, et al
    Retraction notice to "Cervical cancer elimination in low-resource countries: low-cost strategy" [International Journal of Gynecological Cancer, Volume 35 Issue 9 (2025) 101828].
    Int J Gynecol Cancer. 2026;36:104540.
    PubMed    


  328. ELMEHRATH AO, Njala B, Sakala D, Nogueras-Gonzalez GM, et al
    Demographic and social determinants of human immunodeficiency virus status among women with cervical cancer in a low-resource setting.
    Int J Gynecol Cancer. 2025 Dec 26:102867. doi: 10.1016/j.ijgc.2025.102867.
    PubMed    
    Abstract available

  329. SARDINHA TG, Vale DB, Discacciati MG, Triglia RM, et al
    Diagnostic performance and clinical utility of p16 immunostaining in a population-based HPV DNA screening program.
    Int J Gynecol Cancer. 2026;36:104451.
    PubMed    
    Abstract available

  330. O'SHEA J, Yu K, Chang D, Khaw P, et al
    Survival and patterns of failure in small cell neuroendocrine carcinoma of the cervix treated with definitive chemoradiotherapy.
    Int J Gynecol Cancer. 2026;36:102874.
    PubMed    
    Abstract available

  331. KOBAYASHI M, Yao JA, Lee MW, Nakagawa S, et al
    Relative survival of large cell to small cell neuroendocrine carcinoma of the uterine cervix.
    Int J Gynecol Cancer. 2026;36:102852.
    PubMed    
    Abstract available

  332. SHI J, Du H
    Correspondence on "Pelvic radiotherapy combined with immunotherapy and chemotherapy for stage IVB cervical cancer: a retrospective study" by Zhou et al.
    Int J Gynecol Cancer. 2026 Jan 20:104505. doi: 10.1016/j.ijgc.2026.104505.
    PubMed    


  333. EBRAHIMOGHLI R, Agaei MH, Hakimi MH, Moradoghli F, et al
    Temporal trends and sources of variation in late-stage cervical cancer diagnosis in low- and middle-income countries: a systematic review and meta-analysis.
    Int J Gynecol Cancer. 2026 Jan 28:104479. doi: 10.1016/j.ijgc.2026.104479.
    PubMed    
    Abstract available

  334. WANG L, Wei Y, Wu Q
    Correspondence on "Identifying possible candidate population for adjuvant radiotherapy de-escalation for intermediate-risk cervical cancer" by Matsuo et al.
    Int J Gynecol Cancer. 2025;35:102710.
    PubMed    


  335. NAGAR A, Samanta A, Chopra S, Mittal P, et al
    CT vs. MRI for image-guided brachytherapy in locally advanced cervical cancer: A Propensity Score Matched Analysis.
    Int J Radiat Oncol Biol Phys. 2026 Feb 13:S0360-3016(26)00379.
    PubMed    
    Abstract available

  336. SMITH EE, Heintz JR, Chesnokova A, Taunk NK, et al
    Improving treatment of radiation-induced premature ovarian insufficiency after cervical cancer: A practice quality improvement initiative.
    Int J Radiat Oncol Biol Phys. 2026 Feb 14:S0360-3016(26)00389.
    PubMed    
    Abstract available

  337. CUSCHIERI K, Latsuzbaia A, McMahon H, Giubbi C, et al
    Clinical performance assessment of the Papilloplex HR-HPV assay on self-taken urine and vaginal swab samples: findings from a multicentre European study.
    J Clin Pathol. 2025 Nov 7:jcp-2025-210211. doi: 10.1136/jcp-2025-210211.
    PubMed    
    Abstract available

  338. SPAMPINATO S, Kutluyer S, Almaz S, Schuur N, et al
    Impact of primary radiotherapy on the psychosocial well-being of patients with locally advanced cervical cancer (IMPRaCC study).
    Radiother Oncol. 2026 Jan 30:111405. doi: 10.1016/j.radonc.2026.111405.
    PubMed    
    Abstract available

  339. YANG XL, Zhu JW, Wang C, Zhou YC, et al
    Radiation- versus surgery-based treatment for patients with resectable IIIC1 cervical adenocarcinoma.
    Radiother Oncol. 2026;216:111370.
    PubMed    
    Abstract available

  340. CORBEAU A, Spampinato S, Charnalia M, Ranjan N, et al
    Normal tissue complication probability models for gastrointestinal toxicity after adjuvant (chemo)radiotherapy for cervical cancer in the PARCER trial.
    Radiother Oncol. 2026;218:111444.
    PubMed    
    Abstract available

  341. LIN S, Zhong J, Yuan S, Su M, et al
    Integrated single-cell and bulk RNA sequencing unravels neutrophil heterogeneity and validates SPP1 as a prognostic biomarker in cervical cancer.
    BMC Cancer. 2026 Jan 30. doi: 10.1186/s12885-026-15636.
    PubMed    
    Abstract available

  342. YANG XL, He JL, Wang TJ, Ran L, et al
    Reappraisal of the prognostic significance of vaginal invasion, parametrial invasion and lymph node metastasis in locally advanced cervical cancer patients receiving concurrent chemoradiotherapy: a multi-center large cohort study.
    BMC Cancer. 2026 Jan 29. doi: 10.1186/s12885-026-15661.
    PubMed    
    Abstract available

  343. FEI C, Chen W, Liu J, Wang J, et al
    A real-world multicenter study on opportunistic cervical cancer screening in hospital in China: comparison of TruScreen device, cytology, and HPV testing for detecting high-grade cervical lesions.
    BMC Cancer. 2026 Feb 4. doi: 10.1186/s12885-026-15590.
    PubMed    


  344. WANGUSI R, Ngugi E, Wafula S, Awuor P, et al
    Enhancing cervical cancer screening uptake through self-sampling for HPV DNA testing: insights and results from implementing in routine HIV clinics serving women living with HIV in Nairobi, Kenya, 2021-2024.
    BMC Cancer. 2026 Feb 21. doi: 10.1186/s12885-026-15771.
    PubMed    


  345. ANENA S, Okello MO, Ouma RC, Olum R, et al
    Uptake of cervical cancer screening services among women of reproductive age enrolled in HIV care: a facility-based cross-sectional study in rural Northern Uganda.
    BMC Cancer. 2026 Feb 16. doi: 10.1186/s12885-026-15708.
    PubMed    


  346. ILIC I, Babic G, Sipetic Grujicic S, Zivanovic Macuzic I, et al
    Concurrent depression and anxiety in women undergoing additional diagnostic procedures due to positive screening for cervical cancer.
    PLoS One. 2026;21:e0342492.
    PubMed    
    Abstract available

  347. HADDADI M, Golestani A, Farzi Y, Rezaei N, et al
    Iran is falling behind WHO cervical cancer elimination targets: HPV vaccination coverage and cervical cancer screening participation in 2021.
    PLoS One. 2026;21:e0341888.
    PubMed    
    Abstract available

  348. KIM WJ, Kim YW
    Association between cervical conization and pregnancy outcomes: A nationwide population-based cohort study.
    PLoS One. 2026;21:e0341660.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum


;